Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Large Insider Purchases

Institutional-Scale SEC Form 4 Buy Signals

The Signal of $1M+ Conviction

When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.

Filing Date Trade Date Ticker Company Name Reporting Person Relationship Industry Type Price Qty Total, $ Owned After Change, %
2018-06-29 04:01 2018-06-26 EGN N/A ICAHN CARL C Other Other BUY $70.39 1,470,415 $103,499,130 4,696,121 +45.6%
2018-06-29 02:50 2018-06-27 MIC Macquarie Infrastructure Corp MACQUARIE GROUP LTD 10% owner Wholesale-Petroleum & Petroleum Products (No Bulk Stations) BUY $42.30 151,200 $6,395,473 9,548,967 +1.6%
2018-06-29 01:22 2018-06-25 KZR Kezar Life Sciences, Inc. BAY CITY CAPITAL LLC 10% owner Pharmaceutical Preparations BUY $15.00 150,000 $2,250,000 622,229 +31.8%
2018-06-28 23:14 2018-06-26 NS N/A GREEHEY WILLIAM E Director Other BUY $24.17 413,736 $9,999,999 3,899,605 +11.9%
2018-06-28 00:09 2018-06-25 EPRT ESSENTIAL PROPERTIES REALTY TRUST, INC. Eldridge Industries, LLC 10% owner Real Estate Investment Trusts BUY $14.00 7,785,611 $108,998,554 7,785,611 +100.0%
2018-06-27 21:13 2018-06-27 CSSE N/A ROUHANA WILLIAM J JR Director, Officer, 10% owner - Chairman and CEO Other BUY $25.00 40,000 $1,000,000 40,000 +100.0%
2018-06-28 01:20 2018-06-25 KZR Kezar Life Sciences, Inc. Cormorant Asset Management, LP 10% owner Pharmaceutical Preparations BUY $15.00 250,000 $3,750,000 1,572,909 +18.9%
2018-06-27 23:53 2018-06-25 KZR Kezar Life Sciences, Inc. Morningside Venture Investments Ltd 10% owner Pharmaceutical Preparations BUY $15.00 250,000 $3,750,000 2,309,052 +12.1%
2018-06-27 23:15 2018-06-25 XERS N/A Redmile Group, LLC 10% owner Other BUY $15.00 666,668 $10,000,020 2,412,642 +38.2%
2018-06-27 23:58 2018-06-25 XERS N/A Flynn James E 10% owner, Other Other BUY $15.00 750,000 $11,250,000 1,498,666 +100.2%
2018-06-26 23:30 2018-06-22 EIDX N/A BridgeBio Pharma LLC 10% owner Other BUY $17.00 1,000,000 $17,000,000 19,614,655 +5.4%
2018-06-27 00:02 2018-06-22 TWLVU N/A Elkin Dimitri Officer, 10% owner - CEO Other BUY $10.00 475,000 $4,750,000 5,550,000 +9.4%
2018-06-26 23:57 2018-06-25 APTX N/A New Leaf Venture Management III, L.L.C. 10% owner Other BUY $16.00 250,000 $4,000,000 368,345 +211.2%
2018-06-26 23:50 2018-06-25 APTX N/A Koppel Adam Director Other BUY $16.00 400,000 $6,400,000 2,225,092 +21.9%
2018-06-26 23:50 2018-06-25 APTX N/A Gould Terry P Director, 10% owner Other BUY $16.00 150,000 $2,400,000 1,115,910 +15.5%
2018-06-26 23:53 2018-06-25 APTX N/A Ratcliffe Liam Director, 10% owner Other BUY $16.00 250,000 $4,000,000 368,345 +211.2%
2018-06-26 23:30 2018-06-22 DDR SITE Centers Corp. Otto Alexander Director, 10% owner Real Estate Investment Trusts BUY $17.86 1,124,158 $20,080,497 31,353,074 +3.7%
2018-06-26 23:55 2018-06-25 APTX N/A Longitude Capital Partners II, LLC 10% owner Other BUY $16.00 150,000 $2,400,000 3,190,079 +4.9%
2018-06-26 23:56 2018-06-25 APTX N/A Frazier Life Sciences VIII, L.P. 10% owner Other BUY $16.00 150,000 $2,400,000 3,190,079 +4.9%
2018-06-26 23:54 2018-06-25 APTX N/A Topper James N Director, 10% owner Other BUY $16.00 150,000 $2,400,000 3,190,079 +4.9%
2018-06-26 23:49 2018-06-25 APTX N/A ENRIGHT PATRICK G Director Other BUY $16.00 150,000 $2,400,000 3,190,079 +4.9%
2018-06-26 23:44 2018-06-25 APTX N/A ADAMS STREET PARTNERS LLC 10% owner Other BUY $16.00 150,000 $2,400,000 1,115,910 +15.5%
2018-06-27 00:32 2018-06-22 LXRX LEXICON PHARMACEUTICALS, INC. Invus Public Equities, L.P. Director, 10% owner Pharmaceutical Preparations BUY $12.99 253,725 $3,295,177 3,333,376 +8.2%
2018-06-26 02:16 2018-06-25 XERS N/A Palmetto Partners, Ltd. 10% owner Other BUY $15.00 150,000 $2,250,000 2,110,061 +7.7%
2018-06-25 18:35 2018-06-22 GFN N/A Havner Family Trust 10% owner Other BUY $12.05 87,363 $1,052,724 3,615,508 +2.5%
2018-06-25 18:31 2018-06-22 GFN N/A Havner LeeAnn R 10% owner Other BUY $12.05 87,363 $1,052,724 3,625,008 +2.5%
2018-06-26 04:44 2018-06-21 EGN N/A ICAHN CARL C Other Other BUY $63.70 225,706 $14,376,524 3,225,706 +7.5%
2018-06-26 00:44 2018-06-21 MIC Macquarie Infrastructure Corp MACQUARIE GROUP LTD 10% owner Wholesale-Petroleum & Petroleum Products (No Bulk Stations) BUY $42.36 385,752 $16,340,223 9,397,767 +4.3%
2018-06-25 19:43 2018-06-21 ESPR Esperion Therapeutics, Inc. BIOTECH TARGET N V 10% owner Pharmaceutical Preparations BUY $38.57 60,000 $2,314,224 3,132,964 +2.0%
2018-06-26 00:28 2018-06-21 ETM N/A FIELD JOSEPH M Director, Officer - Chairman Emeritus Other BUY $7.79 370,000 $2,884,076 5,209,559 +7.6%
2018-06-23 01:56 2018-06-22 EIDX N/A Kumar Neil Director, Officer, 10% owner - Chief Executive Officer Other BUY $17.00 1,000,000 $17,000,000 19,614,655 +5.4%
2018-06-22 16:16 2018-06-06 KML N/A Grosvenor Holdings, L.L.C. 10% owner Other BUY $16.03 297,900 $4,774,235 82,900 +100.0%
2018-06-23 01:56 2018-06-22 EIDX N/A Satvat Ali J. Director, 10% owner Other BUY $17.00 1,000,000 $17,000,000 19,614,655 +5.4%
2018-06-23 02:00 2018-06-22 EIDX N/A Shah Rajeev M. Director Other BUY $17.00 1,058,824 $18,000,008 2,162,671 +95.9%
2018-06-23 02:23 2018-06-21 ECOR electroCore, Inc. Merck Global Health Innovation Fund, LLC 10% owner Electromedical & Electrotherapeutic Apparatus BUY $15.00 166,666 $2,499,990 3,346,032 +5.2%
2018-06-22 23:21 2018-06-20 LRAD Genasys Inc. AWM Investment Company, Inc. 10% owner Household Audio & Video Equipment BUY $2.47 407,200 $1,005,784 4,950,706 +9.0%
2018-06-22 23:07 2018-06-20 DDR SITE Centers Corp. Otto Alexander Director, 10% owner Real Estate Investment Trusts BUY $17.88 485,580 $8,682,607 30,228,916 +1.6%
2018-06-22 16:16 2018-06-06 KML N/A Grosvenor Capital Management, L.P. 10% owner Other BUY $16.03 297,900 $4,774,235 82,900 +100.0%
2018-06-22 23:48 2018-06-20 KIN N/A Park West Asset Management LLC 10% owner Other BUY $9.50 845,262 $8,029,989 6,002,053 +16.4%
2018-06-23 02:33 2018-06-22 EIDX N/A RA CAPITAL MANAGEMENT, LLC Director Other BUY $17.00 1,058,824 $18,000,008 2,162,671 +95.9%
2018-06-22 23:37 2018-06-20 APEN N/A Crawford Matthew S Director, 10% owner Other BUY $5.50 363,500 $1,999,250 417,215 +676.7%
2018-06-22 00:19 2018-06-19 LGCY N/A Baines Creek Capital, LLC 10% owner Other BUY $6.61 161,725 $1,068,938 14,399,501 +1.1%
2018-06-22 02:45 2018-06-20 MIC Macquarie Infrastructure Corp MACQUARIE GROUP LTD 10% owner Wholesale-Petroleum & Petroleum Products (No Bulk Stations) BUY $42.46 62,500 $2,653,750 9,012,015 +0.7%
2018-06-22 01:29 2018-06-19 NRESF NEXPOINT REAL ESTATE STRATEGIES FUND DONDERO JAMES D Officer, 10% owner - See Remarks Other BUY $20.90 104,348 $2,180,872 181,973 +134.4%
2018-06-22 01:57 2018-06-19 INFI N/A BVF PARTNERS L P/IL 10% owner Other BUY $1.65 3,942,091 $6,504,450 1,167,191 +100.0%
2018-06-20 23:50 2018-06-18 USX N/A FULLER MAX L Director, Officer, 10% owner, Other - Executive Chairman Other BUY $16.00 953,125 $15,250,000 8,261,776 +13.0%
2018-06-20 23:14 2018-06-18 DDR SITE Centers Corp. Otto Alexander Director, 10% owner Real Estate Investment Trusts BUY $17.19 707,299 $12,161,865 29,743,336 +2.4%
2018-06-20 23:52 2018-06-18 USX N/A Fuller William Eric Director, Officer, 10% owner, Other - President & CEO Other BUY $16.00 296,875 $4,750,000 599,098 +98.2%
2018-06-20 23:30 2018-06-18 VTVT vTv Therapeutics Inc. PERELMAN RONALD O 10% owner Pharmaceutical Preparations BUY $4.38 570,776 $2,499,999 3,757,218 +17.9%
2018-06-21 01:07 2018-06-19 SCOO N/A Mill Road Capital II, L.P. 10% owner Other BUY $19.98 400,000 $7,992,000 2,423,516 +19.8%
SHOW ENTRIES

Institutional Conviction in Form 4

Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.

Filtering the Market Noise

Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.